Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Benjamin Meigs, M.D.

Co-Author

This page shows the publications co-authored by James Meigs and Aaron Leong.
Connection Strength

5.048
  1. Mendelian Randomization Analysis of Hemoglobin A1c as a Risk Factor for Coronary Artery Disease. Diabetes Care. 2019 07; 42(7):1202-1208.
    View in: PubMed
    Score: 0.797
  2. Prediction of Type 2 Diabetes by Hemoglobin A1c in Two Community-Based Cohorts. Diabetes Care. 2018 01; 41(1):60-68.
    View in: PubMed
    Score: 0.732
  3. Type 2 Diabetes Genetic Predisposition, Obesity, and All-Cause Mortality Risk in the U.S.: A Multiethnic Analysis. Diabetes Care. 2016 Apr; 39(4):539-46.
    View in: PubMed
    Score: 0.651
  4. Type 2 Diabetes Prevention: Implications of Hemoglobin A1c Genetics. Rev Diabet Stud. 2015 Fall-Winter; 12(3-4):351-62.
    View in: PubMed
    Score: 0.650
  5. Hypoglycemia in Diabetes Mellitus as a Coronary Artery Disease Risk Factor in Patients at Elevated Vascular Risk. J Clin Endocrinol Metab. 2016 Feb; 101(2):659-68.
    View in: PubMed
    Score: 0.644
  6. Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis. PLoS Med. 2021 03; 18(3):e1003553.
    View in: PubMed
    Score: 0.231
  7. Simultaneous Consideration of HbA1c and Insulin Resistance Improves Risk Assessment in White Individuals at Increased Risk for Future Type 2 Diabetes. Diabetes Care. 2020 08; 43(8):e90-e92.
    View in: PubMed
    Score: 0.220
  8. Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose. Diabetologia. 2018 06; 61(6):1315-1324.
    View in: PubMed
    Score: 0.189
  9. A Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction. Curr Diab Rep. 2017 Nov 04; 17(12):135.
    View in: PubMed
    Score: 0.183
  10. Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. PLoS Med. 2017 Sep; 14(9):e1002383.
    View in: PubMed
    Score: 0.182
  11. Trans-ethnic Meta-analysis and Functional Annotation Illuminates the Genetic Architecture of Fasting Glucose and Insulin. Am J Hum Genet. 2016 Jul 07; 99(1):56-75.
    View in: PubMed
    Score: 0.167
  12. Type 2 Diabetes Partitioned Polygenic Scores Associate With Disease Outcomes in 454,193 Individuals Across 13 Cohorts. Diabetes Care. 2022 03 01; 45(3):674-683.
    View in: PubMed
    Score: 0.062
  13. The trans-ancestral genomic architecture of glycemic traits. Nat Genet. 2021 06; 53(6):840-860.
    View in: PubMed
    Score: 0.059
  14. Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19. Diabetes Care. 2020 12; 43(12):2938-2944.
    View in: PubMed
    Score: 0.056
  15. A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus. Front Genet. 2020; 11:615.
    View in: PubMed
    Score: 0.055
  16. Impact of Rare and Common Genetic Variants on Diabetes Diagnosis by Hemoglobin A1c in Multi-Ancestry Cohorts: The Trans-Omics for Precision Medicine Program. Am J Hum Genet. 2019 10 03; 105(4):706-718.
    View in: PubMed
    Score: 0.052
  17. Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci. Diabetes. 2016 10; 65(10):3200-11.
    View in: PubMed
    Score: 0.042
  18. A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease. Nat Commun. 2015 May 28; 6:7060.
    View in: PubMed
    Score: 0.039
  19. Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. Nat Commun. 2015 Jan 29; 6:5897.
    View in: PubMed
    Score: 0.038
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.